Related Experiment Video
Updated: Jul 19, 2026

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
Orbit and eyelid hemangiomas: is there a relationship between location and ocular problems?
Josée Dubois1, Jean Milot, Brigitte Ingrid Jaeger
1Department of Medical Imaging, Ste-Justine Mother-Child University Hospital, Montreal, Quebec, Canada. josee-dubois@ssss.gouv.qc.ca
Purpose:
Infantile hemangiomas of the orbit and eyelid can cause serious ocular problems, such as astigmatism and amblyopia. Magnetic resonance imaging and ultrasonography are the best ways to establish the diagnosis and to evaluate the extent of the lesion. Our goal was to correlate the lesion location with the visual impairment.
Material And Methods:
This was a retrospective study (1992-2004) of 63 cases of orbit and eyelid hemangiomas (13 male, 50 female patients; ages: 1 day old to 3 years old). Imaging methods were magnetic resonance imaging or computed tomographic-scanning and color Doppler ultrasonography. The anatomic definition was palpebral, extraconal, and extraconal with intraconal involvement. All patients had ophthalmologic evaluations.
Results:
The hemangiomas were palpebral (n = 32) (normal vision: 19; amblyopia and/or astigmatism: 13), extraconal, and extraconal with intraconal involvement (n = 31) (normal vision: 4; amblyopia and/or astigmatism: 27).
Limitations:
This study was small; a prospective study is needed.
Conclusion:
Orbit and eyelid hemangiomas need to be carefully evaluated by an ophthalmologist. Extraconal and intraconal hemangiomas are more frequently associated with ocular involvement. However, ocular complications can occur in palpebral lesions.
Related Concept Videos
Accessory Structures of the Eye
Glaucoma: Overview
Microbiome of the Eye
Muscles of the Eye
Extraocular Muscles
The six extraocular muscles surround the eyeball and control its movements. They are responsible for a wide range of eye motions, including looking up, down, left, right, and rotating...
Angle Closure Glaucoma: Treatment
Ophthalmic Drug Delivery Systems
